Cadence Pharmaceuticals Inc (CADX) Gross Profit Margin starting from the fourth quarter 2013 to fourth quarter 2012, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Cadence Pharmaceuticals Inc  (CADX)


Cadence Pharmaceuticals Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CADX Gross Profit Margin (Dec 31 2013)
Q4 		(Sep 30 2013)
Q3 		(Jun 30 2013)
Q2 		(Mar 31 2013)
Q1 		(Dec 31 2012)
Q4
Y / Y Revenue Change 105.62 %
Seq. Revenue Change 21.95 %
Revenue In Millions $35.31
Gross Profit Margin 67.3 %
Gross Profit Margin Total Ranking # 837
Gross Profit In Millions $23.77
Y / Y Gross Profit Change 137.75 %
Seq. Gross Profit Change 25.13 %


Commenting fourth quarter 2013 Gross Profit Margin
Cadence Pharmaceuticals Inc Gross Profit grew by 25.13 % in Q4 sequentially to 24 millions, while Revenue increased by 21.95 %, this led to improvement in the company's Gross Profit Margin to 67.3 % a new company high.


Observing fourth quarter 2013 results within Biotechnology & Pharmaceuticals industry 15 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 828 to 837.
Learn about Gross Margin
CADX's Gross Profit Margin fourth quarter 2013 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 16
Healthcare Sector # 105
Overall # 659

Gross Profit Margin Statistics
High Average Low
67.3 % 63.7 % 58.2 %
(Dec 31 2013)   (Dec 31 2012)


CADX Gross Income Trends • More of CADX's Profitabilty Ratios • CADX Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
CADX's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CADX's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CADX's Competitors
Gross Profit Margin Profit Margin for Cadence Pharmaceuticals Inc's Suppliers
Gross Profit Margin Profit Margin for CADX's Customers

You may also want to know
CADX's Annual Growth Rates CADX's Profitability Ratios CADX's Asset Turnover Ratio CADX's Dividend Growth
CADX's Roe CADX's Valuation Ratios CADX's Financial Strength Ratios CADX's Gross Profit Growth
CADX's Roa CADX's Inventory Turnover Ratio CADX's Growth Rates CADX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2013, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginDec 31 2013 MRQ Gross ProfitDec 31 2013 MRQ Revenue
Lineage Cell Therapeutics Inc   99.82 %$ 1.667  Millions$ 1.670  Millions
Agenus Inc  98.21 %$ 0.386  Millions$ 0.393  Millions
Pluri Inc   96.84 %$ 0.092  Millions$ 0.095  Millions
Seagen Inc   94.44 %$ 63.658  Millions$ 67.409  Millions
Vericel Corporation  87.50 %$ 0.007  Millions$ 0.008  Millions
Biogen Inc   86.85 %$ 1,707.300  Millions$ 1,965.900  Millions
Gentium S.p.a.  85.45 %$ 48.705  Millions$ 56.998  Millions
Acorda Therapeutics Inc   79.98 %$ 74.057  Millions$ 92.593  Millions
Nutrastar International Inc.  77.37 %$ 10.157  Millions$ 13.128  Millions
Bohai Pharmaceuticals Group, Inc.  76.61 %$ 29.627  Millions$ 38.673  Millions
Amgen Inc   75.23 %$ 3,770.000  Millions$ 5,011.000  Millions
Repligen Corp  70.92 %$ 10.909  Millions$ 15.382  Millions
Novavax inc   70.27 %$ 6.147  Millions$ 8.748  Millions
Gilead Sciences Inc   70.06 %$ 2,185.667  Millions$ 3,119.826  Millions
Bio techne Corp  69.74 %$ 58.593  Millions$ 84.017  Millions
Cadence Pharmaceuticals Inc  67.30 %$ 23.765  Millions$ 35.313  Millions
China Biologic Products Holdings Inc   63.42 %$ 27.013  Millions$ 42.592  Millions
Qiagen N v   62.63 %$ 815.490  Millions$ 1,301.984  Millions
Fresh Tracks Therapeutics Inc   62.03 %$ 1.951  Millions$ 3.145  Millions
Enzo Biochem Inc  59.47 %$ 13.636  Millions$ 22.928  Millions
Noho, Inc.  52.92 %$ 0.246  Millions$ 0.465  Millions
Ds Healthcare Group, Inc.  51.41 %$ 1.570  Millions$ 3.055  Millions
Halozyme Therapeutics Inc   50.13 %$ 6.266  Millions$ 12.499  Millions
Xtant Medical Holdings Inc   49.45 %$ 4.084  Millions$ 8.258  Millions
Vaxart Inc   38.38 %$ 7.100  Millions$ 18.500  Millions
Adma Biologics Inc   34.30 %$ 0.780  Millions$ 2.275  Millions
Beam Therapeutics Inc   31.07 %$ 414.600  Millions$ 1,334.400  Millions
Compugen Ltd  29.30 %$ 1.040  Millions$ 3.549  Millions
Zeo Scientifix Inc   29.05 %$ 0.002  Millions$ 0.005  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.